BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
Yaktapour N, Meiss F, Mastroianni J, Zenz T, Andrlova H, Mathew NR, Claus R, Hutter B, Fröhling S, Brors B, Pfeifer D, Pantic M, Bartsch I, Spehl TS, Meyer PT, Duyster J, Zirlik K, Brummer T, Zeiser R.
Yaktapour N, et al. Among authors: brummer t.
J Clin Invest. 2014 Nov;124(11):5074-84. doi: 10.1172/JCI76539. Epub 2014 Oct 20.
J Clin Invest. 2014.
PMID: 25329694
Free PMC article.